Previous work demonstrated the dependence of BCR-FGFR1 on Grb2 for CML-like leukemia, and the importance of PLCγ1 for ZNF198-FGFR1-driven EMS like disease [10]. This evidence concerns the gene ZMYM2 and chronic myelogenous leukemia, BCR-ABL1 positive.